TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 10.9M
Gross Profit 692.6K 6.38%
Operating Income -31.3M -288.57%
Net Income -32.4M -298.53%
EPS (Diluted) $-0.62

Balance Sheet Metrics

Total Assets 58.1M
Total Liabilities 53.6M
Shareholders Equity 4.5M
Debt to Equity 11.96

Cash Flow Metrics

Operating Cash Flow -1.6M
Free Cash Flow -1.6M

Revenue & Profitability Trend

Wellgistics Health Income Statement From 2022 to 2024

Metric202420232022
Revenue i18.1M34.4M32.8M
Cost of Goods Sold i16.4M31.6M27.0M
Gross Profit i1.8M2.8M5.7M
Gross Margin % i9.7%8.1%17.5%
Operating Expenses
Research & Development i-3751.4K
Selling, General & Administrative i6.8M10.1M7.1M
Other Operating Expenses i---
Total Operating Expenses i6.8M10.1M7.1M
Operating Income i-6.1M-12.1M-3.4M
Operating Margin % i-33.9%-35.3%-10.4%
Non-Operating Items
Interest Income i---
Interest Expense i831.5K1.6M287.2K
Other Non-Operating Income120.4K98.1K966.1K
Pre-tax Income i-6.9M-13.6M-2.7M
Income Tax i000
Effective Tax Rate % i0.0%0.0%0.0%
Net Income i-6.9M-13.6M-2.7M
Net Margin % i-37.8%-39.6%-8.4%
Key Metrics
EBITDA i-4.9M-7.2M-2.2M
EPS (Basic) i$-0.15$-0.30$-0.06
EPS (Diluted) i$-0.15$-0.30$-0.06
Basic Shares Outstanding i472520814472000046714665
Diluted Shares Outstanding i472520814472000046714665

Income Statement Trend

Wellgistics Health Balance Sheet From 2022 to 2024

Metric202420232022
Assets
Current Assets
Cash & Equivalents i1.0M1.4K0
Short-term Investments i---
Accounts Receivable i2.7M--
Inventory i9.5M--
Other Current Assets1--
Total Current Assets i15.2M338.4K0
Non-Current Assets
Property, Plant & Equipment i2.1M--
Goodwill i54.8M--
Intangible Assets i22.4M--
Long-term Investments---
Other Non-Current Assets1.4M--
Total Non-Current Assets i42.2M00
Total Assets i57.3M338.4K0
Liabilities
Current Liabilities
Accounts Payable i6.3M1.0M5.2K
Short-term Debt i12.6M350.0K-
Current Portion of Long-term Debt---
Other Current Liabilities---
Total Current Liabilities i38.0M3.2M5.2K
Non-Current Liabilities
Long-term Debt i12.6M--
Deferred Tax Liabilities i---
Other Non-Current Liabilities---
Total Non-Current Liabilities i12.6M00
Total Liabilities i50.6M3.2M5.2K
Equity
Common Stock i5.1K4.5K0
Retained Earnings i-9.8M-2.9M-5.2K
Treasury Stock i---
Other Equity---
Total Shareholders Equity i6.7M-2.9M-5.2K
Key Metrics
Total Debt i25.1M350.0K0
Working Capital i-22.9M-2.9M-5.2K

Balance Sheet Composition

Wellgistics Health Cash Flow Statement From 2022 to 2024

Metric202420232022
Operating Activities
Net Income i-6.9M-2.9M-5.2K
Depreciation & Amortization i1.1M--
Stock-Based Compensation i1.1M--
Working Capital Changes i1.8M764.2K5.2K
Operating Cash Flow i-2.9M-2.1M0
Investing Activities
Capital Expenditures i---
Acquisitions i931.4K--
Investment Purchases i---
Investment Sales i---
Investing Cash Flow i846.4K--
Financing Activities
Share Repurchases i---
Dividends Paid i---
Debt Issuance i0--
Debt Repayment i-135.8K--
Financing Cash Flow i1.6M350.5K0
Free Cash Flow i-1.6M-349.1K0
Net Change in Cash i-400.9K-1.8M0

Cash Flow Trend

Wellgistics Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -5.47
Price to Book 10.27
Price to Sales 1.96
PEG Ratio 0.00

Profitability Ratios

Profit Margin -135.22%
Operating Margin -288.57%
Return on Equity -2,124.65%
Return on Assets -77.95%

Financial Health

Current Ratio 0.36
Debt to Equity 571.67

Per Share Data

EPS (TTM) $-0.77
Book Value per Share $0.07
Revenue per Share $0.59

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
wgrx56.8M-5.4710.27-2,124.65%-135.22%571.67
Walgreens Boots 10.5B27.101.46-69.58%-4.07%409.88
High Tide 248.5M-61.201.77-6.69%-1.76%44.69
PetMed Express 62.6M303.000.650.36%0.15%1.15
Scienture Holdings 19.5M2.370.25-54.26%4.39%5.30
Hong Kong Pharma 11.5M6.262.31-0.59%-0.13%47.60

Financial data is updated regularly. All figures are in the company's reporting currency.